1. The active peptide hormone angiotensin II (AngII) is formed from its pro
hormone angiotensinogen by way of inactive angiotensin I. The highly specif
ic protease, renin, responsible for the initiation of this system was elusi
ve and considered unstable. We isolated it in a pure and stable form from t
he kidney of the pig, human, rat, and land submandibular glands of the mous
e. It was shown that there is only one type of renin nifh highly Stringent
substrate specificity, except certain strains of the mouse which have two g
ene products.
2. The well-known diversity of action of AngII can be attributed to the pre
sence of more than two subtypes, AT(1) and AT(2), as well as multiple signa
lling pathways for both of them,
3. The first subtype AT(1) was shown to mediate most of the traditionally r
ecognized AngII functions such as vasoconstriction, electrolyte homeostasis
etc.
4. Although the identification of the signalling modes of the second subtyp
e AT(2) still remains elusive, we and others have shown evidence that its a
ction is generally antagonistic to that of AT(1).AT(2) inhibits AT(1) (grow
th factor-stimulated cell growth), AT(2) attenuates the vasoconstriction in
duced by AT(1), Since AT(2) seems to mediate nitric oxide formation in the
renal cells, it may initiate a natriuretic pathway in contrast to the sodiu
m-retaining action of AT(1)-mediated AngII action.
5. Newer mechanisms and functions of these and other receptors will be clar
ified by the combination of molecular, cellular and integrated physiologica
l studies.